Favipiravir
Experimental antiviral drug with potential activity against RNA viruses
Favipiravir ▸ Facts ▸ Comments ▸ News ▸ Videos
Favipiravir, sold under the brand name Avigan among others, is an antiviral medication used to treat influenza in Japan. It is also being studied to treat a number of other viral infections, including SARS-CoV-2. Like the experimental antiviral drugs T-1105 and T-1106, it is a pyrazinecarboxamide derivative.
| 0 shares | ShareTweetSavePostSend |
You Might Like
FDC launches Favipiravir oral suspension to treat Covid-19 in IndiaIndiaTimes - Published | |
India welcomes 15 ventilators, 12000 tablets of Favipiravir from IcelandIndia on early Wednesday received a consignment of 15 ventilators, and 12000 tablets of Favipiravir from Iceland as the country combat the second wave of Covid-19 pandemic.IndiaTimes - Published | |
Vivimed gets DGHI nod to make, market FavipiravirIndiaTimes - Published | |
Covid: Favipiravir shows hope in Mumbai trialThe current favipiravir trial was conducted from May 3 to July 3 among 150 patients admitted at Breach Candy Hospital on 75 patients and another 'control group' received some other drugs. "The median..IndiaTimes - Published | |
SC seeks Centre's reply on plea alleging no approval for Remdesivir, Favipiravir to treat Covid-19IndiaTimes - Published | |
COVID-19 medicine: Lupin launches Favipiravir in India at Rs 49 per tabletFavipiravir has received authorisation from the Drug Controller General of India (DCGI) for emergency use on COVID-19 patients as a potential treatmentDNA - Published | |
Cipla to launch COVID-19 treatment drug Favipiravir: CSIRThe death toll has gone up to 30,601 with 740 fatalities reported in the last 24 hours.DNA - Published | |
Anti-viral drug Favipiravir shows clinical improvement in mild, moderate COVID-19 cases: GlenmarkGlenmark announced the launch of the first oral Favipiravir claiming that it is backed by strong clinical evidence showing encouraging results in patients with mild to moderate COVID-19.DNA - Published | |
Fujifilm says COVID-19 drug research may drag on into JulyFujifilm Holdings Corp's research on Avigan as a potential treatment for COVID-19 may drag on until July, the company said on Sunday, a further setback in the Japanese firm's race to find a vaccine.Reuters India - Published | |
Russia backing antiviral drug Avifavir for Covid-19 fight good news for India, say scientistsRussia's approval of the antiviral drug Avifavir to treat Covid-19 is good news for India as it is based on an influenza medication already in advanced clinical trials here, say scientists.Avifavir,..IndiaTimes - Published | |
Mumbai firm may become first in India to develop anti-retroviral drug for Covid-19In an indication of innovation in pharmaceuticals for Covid, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, Favipiravir, from a class of drugs which has shown..IndiaTimes - Published | |
Covid-19: Mumbai firm seeks regulator nod for ARV trialsIn an indication of innovation in pharmaceuticals for Covid-19, Mumbai-based Glenmark may become the first company in India to offer an anti-retroviral, a class of drugs which has shown promise, and is..IndiaTimes - Published |
